Vasa Denticity
Revenue up 19.4% to ₹87.1 Cr; EBITDA ₹7.24 Cr, margin 8.31% vs 8.01%. Margin gain driven by opex cut; gross margin fell ~6 pts amid stock rebuild.
ALFA Concalls
Every earnings call, live and summarised
Earnings calls
Every Vasa Denticity earnings call we streamed: the live audio and our summary of what management said.
Revenue up 19.4% to ₹87.1 Cr; EBITDA ₹7.24 Cr, margin 8.31% vs 8.01%. Margin gain driven by opex cut; gross margin fell ~6 pts amid stock rebuild.
Revenue up 19.4% to ₹87.1 Cr; EBITDA ₹7.24 Cr, margin 8.31% vs 8.01%. Margin gain driven by opex cut; gross margin fell ~6 pts amid stock rebuild.
No quantified FY27 guidance. Long-term: EBITDA margin 13–18% 'over time'; opex 12% of revenue benchmark.
Management reports a repair quarter, successfully addressing inventory shortages in high-margin in-house brands to restore profitability.
Vasa Denticity (Dentalkart) reported a 'repair quarter' focusing on in-house brands and operational automation to improve gross margins and cost-to-serve for Q1 FY27.
Vasa Denticity delivered strong revenue growth but faced a severe margin collapse due to operational mismanagement and inventory stockouts.
Vasa Denticity reported FY26 total income of ₹283 crore with core growth of 33%. Management is shifting focus from aggressive expansion to core business optimization after missing guidance and facing margin compression.
Vasa Denticity (Dentalkart) FY26 Revenue grew 11.8% to ₹278.87 Cr, while EBITDA fell 37.9% to ₹15.43 Cr due to inventory stockouts and currency depreciation.
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.